Entity family

Browse drugs

Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.

3articles mentioning drugs

3drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: tolvaptan ×

tolvaptan

This drug is selected. Its supporting articles are shown below.

Articles mentioning tolvaptan

3 articles · page 1 of 1

Autoimmune small-vessel cerebral vasculitis with refractory SIADH: clinical recovery after V2-receptor antagonism (tolvaptan)

bmjcr · abstract · 2026-06-18 · 1 matching annotations

97.6%

tolvaptan cyclophosphamide Autoimmune small-vessel cerebral vasculitis type 1 diabetes mellitus autoimmune small-vessel vasculitis autoimmune small-vessel CNS vasculitis hypothyroidism autoimmune small-vessel central nervous system (CNS) vasculitis SIADH high-dose corticosteroid therapy

… immunotherapy, consistent with refractory SIADH. Initiation of tolvaptan, a selective vasopressin V2-receptor antagonist, successfully r…

MAGGIC risk score-based risk stratification for selecting patients with heart failure who will benefit from multidisciplinary care

openhrt · abstract · 2025-08-31 · 1 matching annotations

98.0%

amiodarone tolvaptan Heart Failure HF Multidisciplinary team care

…ndard follow-up and required more oral inotropes, tolvaptan and amiodarone. Among those receiving HF team care, the majority (58.2%) had a…

5-010 Preparatory work for a multi-arm, multi-stage randomised controlled trial of adjunctive diuretics in patients hospitalisation with heart failure: pre-mammoth-HF

heartjnl · abstract · 2025-08-13 · 1 matching annotations

95.8%

Spironolactone furosemide Tolvaptan Acetazolamide Digoxin Thiazide Corticosteroid Hypertonic saline Oral sodium chloride Heart failure+3 more

…nhibitors No – foundational therapy for HF, cannot be withheld. Spironolactone No – foundational therapy for HF, cannot be withheld. Methods T…